Complete mesocolic excision versus standard resection for colon cancer: a systematic review and meta-analysis of perioperative safety and an evaluation of the use of a robotic approach.


Journal

Techniques in coloproctology
ISSN: 1128-045X
Titre abrégé: Tech Coloproctol
Pays: Italy
ID NLM: 9613614

Informations de publication

Date de publication:
11 2023
Historique:
received: 05 01 2023
accepted: 17 06 2023
medline: 10 10 2023
pubmed: 7 7 2023
entrez: 6 7 2023
Statut: ppublish

Résumé

Complete mesocolic excision (CME) has been associated with improved oncological outcomes in treatment of colon cancer. However, widespread adoption is limited partly because of the technical complexity and perceived risks of the approach. The aim of out study was to evaluate the safety of CME compared to standard resection and to compare robotic versus laparoscopic approaches. Two parallel searches were undertaken in MEDLINE, Embase and Web of Science databases 12 December 2021. The first was to evaluate IDEAL stage 3 evidence to compare complication rates as a surrogate marker of perioperative safety between CME and standard resection. The second independent search compared lymph node yield and survival outcomes between minimally invasive approaches. There were four randomized control trials (n = 1422) comparing CME to standard resection, and three studies comparing laparoscopic (n = 164) to robotic (n = 161) approaches. Compared to standard resection, CME was associated with a reduction in Clavien-Dindo grade 3 or higher complication rates (3.56% vs. 7.24%, p = 0.002), reduced blood loss (113.1 ml vs. 137.6 ml, p < 0.0001) and greater mean lymph node harvest (25.6 vs. 20.9 nodes, p = 0.001). Between the robotic and laparoscopic groups, there were no significant differences in complication rates, blood loss, lymph node yield, 5-year disease-free survival (OR 1.05, p = 0.87) and overall survival (OR 0.83, p = 0.54). Our study demonstrated improved safety with CME. There was no difference in safety or survival outcomes between robotic and laparoscopic CME. The advantage of a robotic approach may lie in the reduced learning curve and an increased penetration of minimally invasive approach to CME. Further studies are required to explore this. CRD42021287065.

Identifiants

pubmed: 37414915
doi: 10.1007/s10151-023-02838-7
pii: 10.1007/s10151-023-02838-7
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

995-1005

Informations de copyright

© 2023. Springer Nature Switzerland AG.

Références

Bülow S, Harling H, Iversen LH et al (2010) Improved survival after rectal cancer in Denmark. Colorectal Dis 12:e37-42
pubmed: 19614669
Hohenberger W, Weber K, Matzel K et al (2009) Standardized surgery for colonic cancer: complete mesocolic excision and central ligation–technical notes and outcome. Colorectal Dis 11:354–364
doi: 10.1111/j.1463-1318.2008.01735.x pubmed: 19016817
Kong JC, Prabhakaran S, Choy KT et al (2021) Oncological reasons for performing a complete mesocolic excision: a systematic review and meta-analysis. ANZ J Surg 91:124–131
doi: 10.1111/ans.16518 pubmed: 33400369
Wang C, Gao Z, Shen K et al (2017) Safety, quality and effect of complete mesocolic excision vs non-complete mesocolic excision in patients with colon cancer: a systemic review and meta-analysis. Colorectal Dis 19:962–972
doi: 10.1111/codi.13900 pubmed: 28949060
McCulloch P, Altman DG, Campbell WB et al (2009) No surgical innovation without evaluation: the IDEAL recommendations. Lancet 374:1105–1112
doi: 10.1016/S0140-6736(09)61116-8 pubmed: 19782876
De Simoni O, Barina A, Sommariva A et al (2021) Complete mesocolic excision versus conventional hemicolectomy in patients with right colon cancer: a systematic review and meta-analysis. Int J Colorectal Dis 36:881–892
doi: 10.1007/s00384-020-03797-3 pubmed: 33170319
Ow ZGW, Sim W, Nistala KRY et al (2021) Comparing complete mesocolic excision versus conventional colectomy for colon cancer: a systematic review and meta-analysis. Eur J Surg Oncol 47:732–737
doi: 10.1016/j.ejso.2020.09.007 pubmed: 32951936
McCulloch P, Cook JA, Altman DG et al (2013) IDEAL framework for surgical innovation 1: the idea and development stages. BMJ 346:f3012
doi: 10.1136/bmj.f3012 pubmed: 23778427 pmcid: 3685515
Jayne DG, Guillou PJ, Thorpe H et al (2007) Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC trial group. J Clin Oncol 25:3061–3068
doi: 10.1200/JCO.2006.09.7758 pubmed: 17634484
Buunen M, Veldkamp R, Hop WC et al (2009) Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol 10:44–52
doi: 10.1016/S1470-2045(08)70310-3 pubmed: 19071061
Tekkis PP, Senagore AJ, Delaney CP et al (2005) Evaluation of the learning curve in laparoscopic colorectal surgery: comparison of right-sided and left-sided resections. Ann Surg 242:83–91
doi: 10.1097/01.sla.0000167857.14690.68 pubmed: 15973105 pmcid: 1357708
Ruurda JP, Draaisma WA, van Hillegersberg R et al (2005) Robot-assisted endoscopic surgery: a four-year single-center experience. Dig Surg 22:313–320
doi: 10.1159/000088628 pubmed: 16192731
Ng KT, Tsia AKV, Chong VYL (2019) Robotic versus conventional laparoscopic surgery for colorectal cancer: a systematic review and meta-analysis with trial sequential analysis. World J Surg 43:1146–1161
doi: 10.1007/s00268-018-04896-7 pubmed: 30610272
Liao G, Zhao Z, Lin S et al (2014) Robotic-assisted versus laparoscopic colorectal surgery: a meta-analysis of four randomized controlled trials. World J Surg Oncol 12:122
doi: 10.1186/1477-7819-12-122 pubmed: 24767102 pmcid: 4002581
Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1
doi: 10.1186/2046-4053-4-1 pubmed: 25554246 pmcid: 4320440
Higgins JPT, Altman DG, Gøtzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928
doi: 10.1136/bmj.d5928 pubmed: 22008217 pmcid: 3196245
Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
doi: 10.1136/bmj.327.7414.557 pubmed: 12958120 pmcid: 192859
Wan X, Wang W, Liu J et al (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135
doi: 10.1186/1471-2288-14-135 pubmed: 25524443 pmcid: 4383202
Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13
doi: 10.1186/1471-2288-5-13 pubmed: 15840177 pmcid: 1097734
Xu L, Su X, He Z et al (2021) Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial. Lancet Oncol 22:391–401
doi: 10.1016/S1470-2045(20)30685-9 pubmed: 33587893
Yan D, Yang X, Duan Y et al (2020) Comparison of laparoscopic complete mesocolic excision and traditional radical operation for colon cancer in the treatment of stage III colon cancer. J BUON 25:220–226
pubmed: 32277635
Di Buono G, Buscemi S, Cocorullo G et al (2021) Feasibility and safety of laparoscopic complete mesocolic excision (CME) for right-sided colon cancer: short-term outcomes. A randomized clinical study. Ann Surg 274:57–62
doi: 10.1097/SLA.0000000000004557 pubmed: 33177355
Karachun A, Panaiotti L, Chernikovskiy I et al (2020) Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial). Br J Surg 107:499–508
doi: 10.1002/bjs.11387 pubmed: 31872869
Park JS, Kang H, Park SY et al (2019) Long-term oncologic after robotic versus laparoscopic right colectomy: a prospective randomized study. Surg Endosc 33:2975–2981
doi: 10.1007/s00464-018-6563-8 pubmed: 30456502
Spinoglio G, Bianchi PP, Marano A et al (2018) Robotic versus laparoscopic right colectomy with complete mesocolic excision for the treatment of colon cancer: perioperative outcomes and 5-year survival in a consecutive series of 202 patients. Ann Surg Oncol 25:3580–3586
doi: 10.1245/s10434-018-6752-7 pubmed: 30218248
Ceccarelli G, Costa G, Ferraro V et al (2021) Robotic or three-dimensional (3D) laparoscopy for right colectomy with complete mesocolic excision (CME) and intracorporeal anastomosis? A propensity score-matching study comparison. Surg Endosc 35:2039–2048
doi: 10.1007/s00464-020-07600-w pubmed: 32372219
Park JS, Choi GS, Park SY et al (2012) Randomized clinical trial of robot-assisted versus standard laparoscopic right colectomy. Br J Surg 99:1219–1226
doi: 10.1002/bjs.8841 pubmed: 22864881
Watanabe T, Itabashi M, Shimada Y et al (2012) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol 17:1–29
doi: 10.1007/s10147-011-0315-2 pubmed: 22002491
Widmar M, Keskin M, Strombom P et al (2017) Lymph node yield in right colectomy for cancer: a comparison of open, laparoscopic and robotic approaches. Colorectal Dis 19:888–894
doi: 10.1111/codi.13786 pubmed: 28649796 pmcid: 5642033
D’Annibale A, Pernazza G, Morpurgo E et al (2010) Robotic right colon resection: evaluation of first 50 consecutive cases for malignant disease. Ann Surg Oncol 17:2856–2862
doi: 10.1245/s10434-010-1175-0 pubmed: 20567918
Kang J, Park YA, Baik SH et al (2016) A comparison of open, laparoscopic, and robotic surgery in the treatment of right-sided colon cancer. Surg Laparosc Endosc Percutan Tech 26:497–502
doi: 10.1097/SLE.0000000000000331 pubmed: 27846182
Rawlings AL, Woodland JH, Vegunta RK et al (2007) Robotic versus laparoscopic colectomy. Surg Endosc 21:1701–1708
doi: 10.1007/s00464-007-9231-y pubmed: 17353988
Yozgatli TK, Aytac E, Ozben V et al (2019) Robotic complete mesocolic excision versus conventional laparoscopic hemicolectomy for right-sided colon cancer. J Laparoendosc Adv Surg Tech A 29:671–676
doi: 10.1089/lap.2018.0348 pubmed: 30807257

Auteurs

J Xu (J)

Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, 305 Grattan St, Melbourne, 3000, Australia. drjenniferxu@gmail.com.

H M Mohan (HM)

Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, 305 Grattan St, Melbourne, 3000, Australia.
Austin Health, Melbourne, VIC, Australia.

C Fleming (C)

Department of Colorectal Surgery, University Hospital Limerick, Limerick, Ireland.

J T Larach (JT)

Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, 305 Grattan St, Melbourne, 3000, Australia.
Department of Oncology, Sir Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.
Department of Digestive Surgery, Pontificia Universidad Católica de Chile, Santiago, Chile.

S S Apte (SS)

Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, 305 Grattan St, Melbourne, 3000, Australia.

L C L Cohen (LCL)

Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, 305 Grattan St, Melbourne, 3000, Australia.

D Miskovic (D)

St. Marks, London, UK.

W Jiang (W)

Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, 305 Grattan St, Melbourne, 3000, Australia.

A G Heriot (AG)

Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, 305 Grattan St, Melbourne, 3000, Australia.
Department of Oncology, Sir Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.

S K Warrier (SK)

Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, 305 Grattan St, Melbourne, 3000, Australia.
Department of Oncology, Sir Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH